The inconvenient reality of AI-assisted embryo selection in IVF

IF 58.7 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Nature Medicine Pub Date : 2024-10-01 DOI:10.1038/s41591-024-03289-9

Dorit C. Kieslinger, Cornelis B. Lambalk, Carlijn G. Vergouw

引用次数: 0

Abstract

Artificial intelligence is being hyped for its potential to revolutionize assisted reproduction, including embryo selection — but a new study reveals that the inflated expectations of new technologies are not always justified.

Abstract Image

查看原文本刊更多论文

人工智能辅助试管婴儿胚胎选择的不便现实

人工智能因其有望彻底改变包括胚胎选择在内的辅助生殖技术而受到热捧，但一项新的研究表明，对新技术的过高期望并不总是合理的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Medicine 医学-生化与分子生物学

CiteScore

100.90

自引率

0.70%

发文量

525

审稿时长

1 months

期刊介绍： Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.